Author + information
- Received February 25, 2009
- Revision received April 14, 2009
- Accepted April 28, 2009
- Published online October 6, 2009.
- Theodoros D. Karamitsos, MD, PhD*,
- Jane M. Francis, DCC(R), DNM*,
- Saul Myerson, MD*,
- Joseph B. Selvanayagam, MBBS, DPhil† and
- Stefan Neubauer, MD*,* ()
- ↵*Reprint requests and correspondence:
Dr. Stefan Neubauer, Department of Cardiovascular Medicine, John Radcliffe Hospital, Headley Way, Headington, OX3 9DU Oxford, United Kingdom
Noninvasive imaging plays a central role in the diagnosis of heart failure, assessment of prognosis, and monitoring of therapy. Cardiovascular magnetic resonance (CMR) offers a comprehensive assessment of heart failure patients and is now the gold standard imaging technique to assess myocardial anatomy, regional and global function, and viability. Furthermore, it allows assessment of perfusion and acute tissue injury (edema and necrosis), whereas in nonischemic heart failure, fibrosis, infiltration, and iron overload can be detected. The information derived from CMR often reveals the underlying etiology of heart failure, and its high measurement accuracy makes it an ideal technique for monitoring disease progression and the effects of treatment. Evidence on the prognostic value of CMR-derived parameters in heart failure is rapidly emerging. This review summarizes the advantages of CMR for patients with heart failure and its important role in key areas.
- left ventricular dysfunction
- heart failure
- cardiovascular magnetic resonance imaging
Funded by the British Heart Foundation, the UK Medical Research Council, the National Institute for Health Research Biomedical Research Centre Programme, and Heart Research UK.
- Received February 25, 2009.
- Revision received April 14, 2009.
- Accepted April 28, 2009.
- American College of Cardiology Foundation
- How Does CMR Work?
- CMR Safety
- What Are the Imaging Questions in HF That CMR Has to Answer?
- CMR and Specific Causes of HF
- Assessment of Mechanical Dyssynchrony With CMR
- CMR for Cardiac Stem Cell Therapy
- Prognostic Information From CMR in HF
- Future Perspective